Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,365,264
  • Shares Outstanding, K 1,746,330
  • Annual Sales, $ 27,390 M
  • Annual Income, $ 477,000 K
  • 36-Month Beta 1.50
  • Price/Sales 3.82
  • Price/Cash Flow 12.51
  • Price/Book 3.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.99 +3.86%
on 04/06/18
63.07 -6.15%
on 03/21/18
-3.46 (-5.52%)
since 03/20/18
3-Month
55.58 +6.50%
on 02/09/18
64.60 -8.37%
on 01/25/18
-0.12 (-0.20%)
since 01/19/18
52-Week
42.88 +38.04%
on 05/18/17
64.60 -8.37%
on 01/25/18
+15.21 (+34.58%)
since 04/20/17

Most Recent Stories

More News
Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer

Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular (CV) health, today announced that Aaron Berg...

ABT : 59.19 (-1.15%)
AMRN : 2.94 (-1.67%)
Top Analyst Reports for Goldman Sachs, Abbott & Altria

Top Analyst Reports for Goldman Sachs, Abbott & Altria

PYPL : 78.73 (-1.19%)
MO : 57.23 (-0.95%)
ABT : 59.19 (-1.15%)
KMI : 16.47 (-0.42%)
PGR : 61.05 (-0.13%)
GS : 251.96 (-0.87%)
Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023

Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023

ABT : 59.19 (-1.15%)
Relatively Good Performance Detected in Shares of Zimmer Biomet Ho in the Health Care Equipment Industry (ZBH , GMED , ABT , MASI , VAR )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

ZBH : 110.32 (-0.38%)
ABT : 59.19 (-1.15%)
GMED : 52.09 (+1.98%)
Model N Founder & CEO Zack Rinat Named Ernst & Young 2018 Entrepreneur of the Year Semifinalist

Model N, Inc. (NYSE: MODN), the leading provider of revenue management solutions for the pharmaceutical, medical device, high tech, manufacturing and semiconductor industries, announced that...

ABT : 59.19 (-1.15%)
AZN : 35.34 (-0.17%)
STX : 59.64 (-0.43%)
NXPI : 105.15 (-1.88%)
MODN : 17.65 (unch)
AMD : 9.99 (-1.19%)
MU : 50.62 (-1.56%)
GILD : 73.70 (-0.99%)
STM : 21.50 (-1.69%)
PFE : 36.63 (+0.27%)
SNY : 39.96 (-0.50%)
Abbott (ABT) Q1 Earnings & Revenues Top, '18 View Retained

Abbott (ABT) continues to gain from a strong and consistent EPD as well as a robust Medical Devices performance.

ABT : 59.19 (-1.15%)
ABAX : 72.72 (-0.79%)
BIO : 260.68 (-0.60%)
ALGN : 247.07 (-2.26%)
MS, USB, ABT & TXT Leads Q1 Earnings

MS, USB, ABT & TXT Leads Q1 Earnings

TXT : 65.59 (+0.17%)
ABT : 59.19 (-1.15%)
IBM : 144.90 (-1.90%)
USB : 50.43 (-0.53%)
MS : 54.46 (-0.44%)
ISRG : 456.27 (-1.39%)
Q1 Earnings Keep Markets in the Green: MS, USB, ABT & TXT

We are still in the early stages so far, but overall results have been notably better than expected.

TXT : 65.59 (+0.17%)
ABT : 59.19 (-1.15%)
IBM : 144.90 (-1.90%)
USB : 50.43 (-0.53%)
MS : 54.46 (-0.44%)
ISRG : 456.27 (-1.39%)
Abbott Labs (ABT) Breaks Through Support at $59.35

Abbott Labs (NYSE:ABT) has opened bearishly below the pivot of $59.65 today and has reached the first level of support at $59.35. Investors may be interested in a cross of the next downside pivot targets...

ABT : 59.19 (-1.15%)
Abbott (ABT) Beats on Earnings and Revenues in Q1

Abbott (ABT) gains ground on new product launches and delivers strong Q1 results.

ABT : 59.19 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 60.45
1st Resistance Point 59.82
Last Price 59.19
1st Support Level 58.69
2nd Support Level 58.18

See More

52-Week High 64.60
Last Price 59.19
Fibonacci 61.8% 56.30
Fibonacci 50% 53.74
Fibonacci 38.2% 51.18
52-Week Low 42.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar